PHASE II STUDY OF PEMETREXED PLUS INTERMITTENT ERLOTINIB COMBINATION THERAPY FOR PRETREATED ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER WITH DOCUMENTATION OF EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION STATUS

被引：0
|
作者：
Takeuchi, Yoshiko [1 ]
Kijima, Takashi [1 ]
Minami, Seigo [2 ]
Komuta, Kiyoshi [2 ]
Hamaguchi, Masanari [2 ]
Nakatani, Takeshi [2 ]
Koba, Taro [2 ]
Takahashi, Ryo [1 ]
Kida, Hiroshi [1 ]
Nagatomo, Izumi [1 ]
Yamamoto, Suguru [2 ]
Tachibana, Isao [1 ]
Kawase, Ichiro [3 ]
机构：
[1] Osaka Univ, Dept Resp Med Allergy & Rheumat Dis, Grad Sch Med, Suita, Osaka 565, Japan
[2] Osaka Police Hosp, Dept Resp Med, Osaka, Japan
[3] Osaka Prefectural Med Ctr Resp & Allerg Dis, Osaka, Japan
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
pemetrexed; erlotinib; non-small cell lung cancer; combination therapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.10-015
引用
收藏
页码：S568 / S568
页数：1
相关论文
共 50 条
  • [1] Phase II study of pemetrexed plus intermittent erlotinib combination therapy for pretreated advanced non-squamous non-small cell lung cancer with documentation of epidermal growth factor receptor mutation status
    Minami, Seigo
    Kijima, Takashi
    Hamaguchi, Masanari
    Nakatani, Takeshi
    Koba, Taro
    Takahashi, Ryo
    Takeuchi, Yoshiko
    Kida, Hiroshi
    Nagatomo, Izumi
    Yamamoto, Suguru
    Tachibana, Isao
    Komuta, Kiyoshi
    Kawase, Ichiro
    LUNG CANCER, 2013, 82 (02) : 271 - 275
  • [2] A phase II study of oxaliplatin and pemetrexed plus bevacizumab in advanced non-squamous non-small cell lung cancer
    Waples, J. M.
    Auerbach, M.
    Boccia, R.
    Wiggans, R. G.
    Steis, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [3] A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed or Bevacizumab Plus Pemetrexed for Advanced Non-squamous Non-small Cell Lung Cancer
    Yoshida, Hironori
    Kim, Young Hak
    Sakamori, Yuichi
    Nagai, Hiroki
    Ozasa, Hiroaki
    Kaneda, Toshihiko
    Yoshioka, Hiroshige
    Nakagawa, Hiroaki
    Tomii, Keisuke
    Okada, Asuka
    Yoshimura, Kenichi
    Hirabayashi, Masataka
    Hirai, Toyohiro
    ANTICANCER RESEARCH, 2020, 40 (05) : 2981 - 2987
  • [4] Prospective phase II study of cisplatin plus pemetrexed with maintenance of pemetrexed for advanced non-squamous cell non-small cell lung cancer in Japan
    Asami, Kazuhiro
    Kawahara, Masaaki
    Hirashima, Tomonori
    Suzuki, Hidekazu
    Okishio, Kyoichi
    Omachi, Naoki
    Tamiya, Motohiro
    Tamiya, Akihiro
    Hirooka, Aya
    Nakao, Keiko
    Tsuji, Taisuke
    Atagi, Shinji
    THORACIC CANCER, 2014, 5 (04) : 289 - 296
  • [5] Erlotinib versus Pemetrexed for Pretreated Non-Squamous Non-Small Cell Lung Cancer Patients in Clinical Practice
    Zugazagoitia, J.
    Puente, J.
    Gonzalez-Larriba, J. L.
    Manzano, A.
    Sotelo, M.
    Hernandez, S.
    Sanz, J.
    Perez, P.
    Diaz-Rubio, E.
    ONCOLOGY, 2013, 84 (05) : 255 - 264
  • [6] A randomised phase II study of pemetrexed versus pemetrexed plus erlotinib as second-line treatment for locally advanced or metastatic non-squamous non-small cell lung cancer
    Dittrich, Christian
    Papai-Szekely, Zsolt
    Vinolas, Nuria
    Sederholm, Christer
    Hartmann, Joerg T.
    Behringer, Dirk
    Kazeem, Gbenga
    Desaiah, Durisala
    Leschinger, Monika I.
    von Pawel, Joachim
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (09) : 1571 - 1580
  • [7] RETROSPECTIVE STUDY OF COMBINATION CHEMOTHERAPY WITH CISPLATIN PLUS PEMETREXED AS FIRST LINE THERAPY FOR ADVANCED NON-SMALL CELL NON-SQUAMOUS LUNG CANCER
    Inui, Toshiya
    Yokoyama, Takuma
    Takata, Saori
    Hirata, Aya
    Nishizawa, Tomotaka
    Hirukawa, Ichiro
    Wada, Hiroo
    Ishii, Haruyuki
    Takizawa, Hajime
    Goto, Hajime
    RESPIROLOGY, 2013, 18 : 149 - 149
  • [8] Pemetrexed and Cisplatin for Advanced Non-squamous Non-small Cell Lung Cancer in Japanese Patients: Phase II Study
    Kawano, Yuko
    Ohyanagi, Fumiyoshi
    Yanagitani, Noriko
    Kudo, Keita
    Horiike, Atsushi
    Tanimoto, Azusa
    Nishizawa, Hironari
    Ichikawa, Atsuo
    Sakatani, Toshio
    Nakatomi, Katsumi
    Hagiwara, Sachiko
    Ninomiya, Hironori
    Motoi, Noriko
    Ishikawa, Yuichi
    Horai, Takeshi
    Nishio, Makoto
    ANTICANCER RESEARCH, 2013, 33 (08) : 3327 - 3333
  • [9] Phase II Trial of Carboplatin, Pemetrexed, Bevacizumab in Advanced non-Small Cell (non-Squamous) Lung Cancer
    Guarino, Michael J.
    Masters, Gregory A.
    Biggs, David D.
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S698 - S698
  • [10] A phase II study of metformin plus pemetrexed and carboplatin in patients with non-squamous non-small cell lung cancer (METALUNG)
    S. Verma
    S. Chitikela
    V. Singh
    S. Khurana
    D. Pushpam
    D. Jain
    S. Kumar
    Y. Gupta
    P. S. Malik
    Medical Oncology, 40
12345